UMICORE (UMI.BR)

BE0974320526 - Common Stock

10.1  -0.07 (-0.69%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to UMI. UMI was compared to 65 industry peers in the Chemicals industry. UMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. UMI is valued correctly, but it does not seem to be growing. UMI also has an excellent dividend rating.



5

1. Profitability

1.1 Basic Checks

In the past year UMI was profitable.
In the past year UMI had a positive cash flow from operations.
UMI had positive earnings in each of the past 5 years.
UMI had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 3.86%, UMI is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
With a decent Return On Equity value of 10.52%, UMI is doing good in the industry, outperforming 73.02% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.37%, UMI is doing good in the industry, outperforming 74.60% of the companies in the same industry.
UMI had an Average Return On Invested Capital over the past 3 years of 10.16%. This is above the industry average of 7.48%.
Industry RankSector Rank
ROA 3.86%
ROE 10.52%
ROIC 7.37%
ROA(3y)5.48%
ROA(5y)4.42%
ROE(3y)15.54%
ROE(5y)12.57%
ROIC(3y)10.16%
ROIC(5y)8.82%

1.3 Margins

UMI has a Profit Margin (2.11%) which is in line with its industry peers.
In the last couple of years the Profit Margin of UMI has declined.
Looking at the Operating Margin, with a value of 3.23%, UMI is in line with its industry, outperforming 50.79% of the companies in the same industry.
UMI's Operating Margin has been stable in the last couple of years.
UMI's Gross Margin of 8.24% is on the low side compared to the rest of the industry. UMI is outperformed by 84.13% of its industry peers.
UMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.23%
PM (TTM) 2.11%
GM 8.24%
OM growth 3Y19.34%
OM growth 5Y-0.8%
PM growth 3Y49.37%
PM growth 5Y-1.82%
GM growth 3Y13.74%
GM growth 5Y-1.13%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so UMI is creating value.
The number of shares outstanding for UMI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, UMI has less shares outstanding
UMI has a worse debt/assets ratio than last year.

2.2 Solvency

UMI has an Altman-Z score of 2.91. This is not the best score and indicates that UMI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.91, UMI is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
UMI has a debt to FCF ratio of 17.40. This is a negative value and a sign of low solvency as UMI would need 17.40 years to pay back of all of its debts.
With a Debt to FCF ratio value of 17.40, UMI perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
UMI has a Debt/Equity ratio of 0.55. This is a neutral value indicating UMI is somewhat dependend on debt financing.
UMI has a Debt to Equity ratio of 0.55. This is in the lower half of the industry: UMI underperforms 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 17.4
Altman-Z 2.91
ROIC/WACC1.33
WACC5.52%

2.3 Liquidity

A Current Ratio of 1.62 indicates that UMI should not have too much problems paying its short term obligations.
UMI has a Current ratio of 1.62. This is in the lower half of the industry: UMI underperforms 65.08% of its industry peers.
A Quick Ratio of 0.82 indicates that UMI may have some problems paying its short term obligations.
With a Quick ratio value of 0.82, UMI is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.82

1

3. Growth

3.1 Past

UMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.29%.
Measured over the past 5 years, UMI shows a small growth in Earnings Per Share. The EPS has been growing by 4.10% on average per year.
Looking at the last year, UMI shows a very negative growth in Revenue. The Revenue has decreased by -30.40% in the last year.
UMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.90% yearly.
EPS 1Y (TTM)-34.29%
EPS 3Y11.55%
EPS 5Y4.1%
EPS Q2Q%-49.48%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y-4.1%
Revenue growth 5Y5.9%
Sales Q2Q%-14.1%

3.2 Future

UMI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.91% yearly.
UMI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.79% yearly.
EPS Next Y-40.52%
EPS Next 2Y-23.12%
EPS Next 3Y-13.54%
EPS Next 5Y-2.91%
Revenue Next Year-12.13%
Revenue Next 2Y-5.26%
Revenue Next 3Y-2.33%
Revenue Next 5Y-0.79%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.32 indicates a rather cheap valuation of UMI.
Compared to the rest of the industry, the Price/Earnings ratio of UMI indicates a rather cheap valuation: UMI is cheaper than 95.24% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.54, UMI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.19, the valuation of UMI can be described as reasonable.
Based on the Price/Forward Earnings ratio, UMI is valued cheaply inside the industry as 84.13% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of UMI to the average of the S&P500 Index (23.99), we can say UMI is valued rather cheaply.
Industry RankSector Rank
PE 7.32
Fwd PE 9.19

4.2 Price Multiples

UMI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UMI is cheaper than 90.48% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UMI is valued a bit cheaper than the industry average as 68.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.76
EV/EBITDA 4.18

4.3 Compensation for Growth

UMI's earnings are expected to decrease with -13.54% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.78
EPS Next 2Y-23.12%
EPS Next 3Y-13.54%

7

5. Dividend

5.1 Amount

UMI has a Yearly Dividend Yield of 5.77%, which is a nice return.
UMI's Dividend Yield is rather good when compared to the industry average which is at 4.03. UMI pays more dividend than 87.30% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, UMI pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.77%

5.2 History

The dividend of UMI has a limited annual growth rate of 1.00%.
Dividend Growth(5Y)1%
Div Incr Years0
Div Non Decr Years4

5.3 Sustainability

UMI pays out 49.94% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP49.94%
EPS Next 2Y-23.12%
EPS Next 3Y-13.54%

UMICORE

EBR:UMI (12/24/2024, 7:00:00 PM)

10.1

-0.07 (-0.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-26 2024-07-26/bmo
Earnings (Next)02-14 2025-02-14/amc
Inst Owners47.53%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.49B
Analysts54.4
Price Target14.43 (42.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.77%
Dividend Growth(5Y)1%
DP49.94%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.94%
PT rev (3m)-7.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.97%
Valuation
Industry RankSector Rank
PE 7.32
Fwd PE 9.19
P/S 0.14
P/FCF 15.76
P/OCF 2.39
P/B 0.68
P/tB 0.76
EV/EBITDA 4.18
EPS(TTM)1.38
EY13.66%
EPS(NY)1.1
Fwd EY10.88%
FCF(TTM)0.64
FCFY6.35%
OCF(TTM)4.23
OCFY41.9%
SpS74.13
BVpS14.86
TBVpS13.31
PEG (NY)N/A
PEG (5Y)1.78
Profitability
Industry RankSector Rank
ROA 3.86%
ROE 10.52%
ROCE 9.27%
ROIC 7.37%
ROICexc 9.66%
ROICexgc 10.49%
OM 3.23%
PM (TTM) 2.11%
GM 8.24%
FCFM 0.86%
ROA(3y)5.48%
ROA(5y)4.42%
ROE(3y)15.54%
ROE(5y)12.57%
ROIC(3y)10.16%
ROIC(5y)8.82%
ROICexc(3y)14.53%
ROICexc(5y)11.79%
ROICexgc(3y)15.79%
ROICexgc(5y)12.81%
ROCE(3y)13.89%
ROCE(5y)12.23%
ROICexcg growth 3Y19.44%
ROICexcg growth 5Y4.25%
ROICexc growth 3Y18.72%
ROICexc growth 5Y4.1%
OM growth 3Y19.34%
OM growth 5Y-0.8%
PM growth 3Y49.37%
PM growth 5Y-1.82%
GM growth 3Y13.74%
GM growth 5Y-1.13%
F-Score5
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 17.4
Debt/EBITDA 2.27
Cap/Depr 296.37%
Cap/Sales 4.84%
Interest Coverage 6.98
Cash Conversion 117.26%
Profit Quality 41.01%
Current Ratio 1.62
Quick Ratio 0.82
Altman-Z 2.91
F-Score5
WACC5.52%
ROIC/WACC1.33
Cap/Depr(3y)205.73%
Cap/Depr(5y)204.13%
Cap/Sales(3y)2.84%
Cap/Sales(5y)2.79%
Profit Quality(3y)67.38%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.29%
EPS 3Y11.55%
EPS 5Y4.1%
EPS Q2Q%-49.48%
EPS Next Y-40.52%
EPS Next 2Y-23.12%
EPS Next 3Y-13.54%
EPS Next 5Y-2.91%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y-4.1%
Revenue growth 5Y5.9%
Sales Q2Q%-14.1%
Revenue Next Year-12.13%
Revenue Next 2Y-5.26%
Revenue Next 3Y-2.33%
Revenue Next 5Y-0.79%
EBIT growth 1Y-27.85%
EBIT growth 3Y14.45%
EBIT growth 5Y5.05%
EBIT Next Year11.59%
EBIT Next 3Y6.72%
EBIT Next 5Y5.77%
FCF growth 1Y10.53%
FCF growth 3Y19.39%
FCF growth 5YN/A
OCF growth 1Y64.41%
OCF growth 3Y25.44%
OCF growth 5YN/A